This document provides general requirement and guidance on identification, design and development of emerging technologies with potential use in medical laboratories and their preparation for clinical use.
This document is applicable to laboratories transitioning emerging technologies utilizing human samples into medical laboratory examinations for the purpose of providing information for the diagnosis, monitoring, management, prevention, and treatment of disease.
This document does not apply to medical laboratory examinations undergoing validation at which point the technology has become an in-house (laboratory developed) test or in-vitro diagnostic medical device.
PROJECT
ISO/DTS 21385
50.20
Proof sent to secretariat or FDIS ballot initiated: 8 weeks
Oct 6, 2026
To view the full content, you need to register or to log in to your account by clicking on the "Log in" button